Publication | Open Access

Impact of neoadjuvant chemotherapy and stereotactic body radiation therapy (SBRT) on R0 resection rate for borderline resectable and locally advanced pancreatic cancer

Surgical OncologyPancreatic CancerRadiation TherapyMedicineR0 Resection RatePancreatic SurgerySurgeryAdvanced Pancreatic CancerOncologyRadiation OncologyCancer ResearchNeoadjuvant Chemotherapy